跳至主要内容
临床试验/NL-OMON44776
NL-OMON44776已完成3 期

A randomized clinical trial investigating LanreotIde For output reduction in patients with high-output Enterocutaneous fistula or enterostomie - LIFE study

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All adult patients with a high-output fistula (> 500ml/day) or high-output enterostomie (<1500 ml/day) after gastro-intestinal, abdominal wall surgery will be registered from the moment are referred to our multi-disciplinary outpatient treatment team. ;Inclusion criteria for randomization:
  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • * Adult patients minimal 4 weeks after abdominal surgery
  • * Received minimal 2 weeks standard treatment
  • * High output small bowel fistula (>500ml/day) or enterostomy (>1500ml/day) for at least 3 consecutive days.
  • * The diagnosis of fistula origin and localization confirmed by CT/fistulography/ enteral contrast MRI.

排除标准

  • Exclusion criteria
  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • * Treatment with short-acting somatostatin (or analogues) in the last 2 weeks or with a long-acting somatostatine analogue in the last 2 months.
  • * Patients with high output pancreatic fistula after pancreatitis
  • * Patients with symptomatic gallbladder disease

研究者

相似试验

招募中
不适用
A clinical trial investigating the effect of Lanreotide on the reduction of output in patients with high-ouput enterocutaneous fistula or high-output enterostomy
NL-OMON25162Academic Medical Center40
进行中(未招募)
1 期
A clinical trial investigating the effect of Lanreotide on reducing fistula output in patients with high output enterocutaneous fistulaAll adult patients with a small bowel fistula with an output > 500ml/day or a an enterostomy with an output > 1500ml/day after gastro-intestinal, abdominal wall surgery. Randomization is possible if patients are at least 4 weeks postoperative and had at least 2 weeks of standard care (loperamide, codeine, PPI).
EUCTR2013-003998-10-NLAcademic medical center
尚未招募
2 期
To evaluate the effect of Ayurveda treatment Compared to allopath Treatment in the Management of Amavata (Rheumatoid Arthritis)
CTRI/2023/05/053230All India institute of ayurveda
尚未招募
Unknown
Randomized Control Trial on Short Term Effect of High versus Low Position of Umbilical Catheter in NeonatesAortic thrombosisPeripheral vascular compromiseIntraventricular haemorrhageNecrotising enterocolitisAcute kidney injuryHaematurianeonatal umbilical artery catheterCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemNeurological - Other neurological disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCardiovascular - HypertensionReproductive Health and Childbirth - Complications of newbornHypertension
ACTRN12624000331538Hospital Universiti Sains Malaysia180
已完成
不适用
A randomised controlled trial investigating the clinical and cost-effectiveness of a patient self-management programme (SMP) for basic footcare in the elderlyBasic foot careMusculoskeletal Diseases
ISRCTN87471242HS R&D Regional Programme Register - Department of Health (UK)153